Biochemical pharmacology

(Biochem Pharmacol) ISSNs: , 1873-2968

References in Biochemical pharmacology:

Search this table:

Title	Authors	Year
Interaction of cis-diamminedichloroplatinum (II) with single-stranded DNA in the presence or absence of Escherichia coli single-stranded binding protein.	Hoffmann JS, Hübscher U, Michot B, Villani G	1991
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.	Ding L, Balzarini J, Schols D, Meunier B, De Clercq E	1992
4-Hydroxy-17-methylincisterol, an inhibitor of DNA polymerase-alpha activity and the growth of human cancer cells in vitro.	Togashi H, Mizushina Y, Takemura M, Sugawara F, Koshino H, Esumi Y, Uzawa J, Kumagai H, Matsukage A, Yoshida S, Sakaguchi K	1998
Studies on inhibitors of mammalian DNA polymerase alpha and beta: sulfolipids from a pteridophyte, Athyrium niponicum.	Mizushina Y, Watanabe I, Ohta K, Takemura M, Sahara H, Takahashi N, Gasa S, Sugawara F, Matsukage A, Yoshida S, Sakaguchi K	1998
Selective inhibition of the activities of both eukaryotic DNA polymerases and DNA topoisomerases by elenic acid.	Mizushina Y, Murakami C, Ohta K, Takikawa H, Mori K, Yoshida H, Sugawara F, Sakaguchi K	2002
Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo.	Liu X, Huang H, Wang J, Wang C, Wang M, Zhang B, Pan C	2011
Mechanism of cell cycle arrest by sulfoquinovosyl monoacylglycerol with a C18-saturated fatty acid (C18-SQMG).	Murakami C, Miuzno T, Hanaoka F, Yoshida H, Sakaguchi K, Mizushina Y	2004
Analysis of cell cycle regulation by 1-mono-O-acyl-3-O-(alpha-D-sulfoquinovosyl)-glyceride (SQMG), an inhibitor of eukaryotic DNA polymerases.	Murakami C, Takemura M, Yoshida H, Sugawara F, Sakaguchi K, Mizushina Y	2003
Effects of glycolipids from spinach on mammalian DNA polymerases.	Murakami C, Kumagai T, Hada T, Kanekazu U, Nakazawa S, Kamisuki S, Maeda N, Xu X, Yoshida H, Sugawara F, Sakaguchi K, Mizushina Y	2003
Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the "primer grip" region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutants.	Zanoli S, Gemma S, Butini S, Brindisi M, Joshi BP, Campiani G, Fattorusso C, Persico M, Crespan E, Cancio R, Spadari S, Hübscher U, Maga G	2008
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation.	Hatse S, De Clercq E, Balzarini J	1999
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.	De Clercq E	2004
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy.	Balzarini J	1999
Alpha, beta- and beta, gamma-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Correlation between affinity for reverse transcriptase, susceptibility to hydrolysis by phosphodiesterases and anti-retrovirus activity.	Balzarini J, Herdewijn P, Pauwels R, Broder S, De Clercq E	1988
HIV resistance to reverse transcriptase inhibitors.	De Clercq E	1994
Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.	Neyts J, De Clercq E	1994
Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.	Törnevik Y, Ullman B, Balzarini J, Wahren B, Eriksson S	1995
Dancing with chemical formulae of antivirals: a personal account.	De Clercq E	2013

Showing 1 to 18 of 18 entries

Version:20250429